Pharma BD Deal Intelligence

Sun Pharmaceutical Industries Ltd. / URL Pharma, Inc. (generics business)

2012 · Asset Purchase · $60M · Complete

Announcement Sentiment

Positive

Sun Pharma acquired URL Pharma's non-Colcrys generic business from Takeda following Takeda's $800M URL acquisition. Provided Sun with US generics portfolio expansion. Financial terms partially disclosed.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Neutral

Pipeline outcome

Assets Advanced

Assessment window: 5yr post-close.

Key facts

Announced Nov 08, 2012
Closed Jan 31, 2013
Deal value $60M
Deal type Asset Purchase
Therapeutic area Multi-therapeutic generics
Indications Multi-therapeutic generics
Key assets URL non-Colcrys generics portfolio
Mechanism Multiple (generics)

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals